Adjusted relative risk Adjusted odds ratio

Slides:



Advertisements
Similar presentations
Edgar R. Miller III et al. Ann Intern Med. 2005; 142 Clinical Trials of Vitamin E Supplementation and Risk for All-Cause Mortality, Ordered by Dosage of.
Advertisements

* Plus–minus values are means ±SD. † Race was determined by the investigator. ‡ The body-mass index is the weight in kilograms divided by the square of.
Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.
Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:
Ridker PM, et al. Lancet 2009;373: Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.
Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Torbjørn Omland, MD, PHD, MPH, Marc S.
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
Copyright © 2011 American Medical Association. All rights reserved.
All-cause mortality by treatment group
Chronic Kidney Disease in Diabetes
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Clinical Characteristics
AIM HIGH Niacin plus Statin to prevent vascular events
First time a CETP inhibitor shows reduction of serious CV events
Copyright © 2012 American Medical Association. All rights reserved.
by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E
Arterioscler Thromb Vasc Biol
Treatment LDL-C: baseline (mg/dL) LDL-C: 24 mo (mg/dL) p
Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast‐Induced Acute Kidney Injury After Percutaneous Coronary Intervention.
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
FATS- Familial Atherosclerosis Treatment Study
TNT: Baseline and final LDL cholesterol levels
The percentage of subjects with de novo development of renal function impairment (GFR
SAVE: Risk of total mortality associated with reduced kidney function
Adjusted relative mortality risk
Baseline characteristics of patients
A: Epidemiology update
Nat. Rev. Cardiol. doi: /nrcardio
Cardiovascular Disease and CKD: Core Curriculum 2010
Fellström BC, et al. N Engl J Med 2009;360:1455-7
Relative risk of hypertension by quintiles of lipids (mg/dL)
Description of studies for pooled analyses
Figure 4 Observational studies on multiple treatment strategies
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis  Moritz C. Wyler von Ballmoos, MD, MPH, Bernhard.
Volume 375, Issue 9725, Pages (May 2010)
Volume 84, Issue 5, Pages (November 2013)
Baseline Characteristics
Nat. Rev. Cardiol. doi: /nrcardio
Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.
Flow Diagram of the Trial Selection Process
A.V. Khera et al. N Engl J Med 2011;364:127-35
Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.
Baseline Characteristics of the Subjects*
Contributions to Cardiovascular Disease Prediction in the Women’s Health Study* Nancy R. Cook, et al. Circulation 2007;115:
Baseline Characteristics
Study Flow Diagram Thompson A, et al. JAMA 2008;299:
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
Characteristics of included studies
Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4), by number of.
PROSPER: trial design                                                                                                                                                                 
Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)
Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.
Flow chart of search strategy
Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.
Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.
Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.
Javier Escaned et al. JCIN 2018;11:
Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.
Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Presentation transcript:

Relationship between HDL-C concentrations and the risk of ACS and all- cause death after event Adjusted relative risk Adjusted odds ratio Relationship between HDL-C concentrations and the risk of acute coronary syndrome event (left) and all-cause death after event (right). The multivariate adjusted relative risks were plotted as a function of the baseline HDL-C value with the 95% confidence bands shown as the shaded area. HDL cholesterol mg/dL) Kuo-Liong Chien et al, Lipids in Health and Disease 2011,10:215

Relationship between triglyceride concentrations and the risk of ACS and all-cause mortality Adjusted relative risk Adjusted odds ratio Relationship between triglyceride concentrations and the risk of acute coronary syndrome event (left) and all-cause mortality after event (right). The multivariate adjusted relative risks were plotted as a function of the baseline triglyceride value with the 95% confidence bands shown as the shaded area Triglycerides mg/dL) Kuo-Liong Chien et al, Lipids in Health and Disease 2011,10:215

Relationship between glomerular filtration rates and the risk of ACS and all-cause death acute coronary syndrome event all-cause death after event Adjusted relative risk Adjusted odds ratio Relationship between glomerular filtration rates and the risk of acute coronary syndrome event (left) and all-cause death after event (right). The multivariate adjusted relative risks were plotted as a function of the baseline glomerular filtration rate with the 95% confidence bands shown as the shaded area Estimated Glomerular rate ml /min 1.73 m 2 Kuo-Liong Chien et al, Lipids in Health and Disease 2011,10:215